Table 1 The oligonucleotides sequence used in the study

From: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Name

Sequence (5′->3′)

miR-181-b-1 F

AACATTCATTGCTGTCGGTGGGT

U6 F

TGCGGGTGCTCGCTTCGGCAGC

miR-181b-1 precursor F

AATCTCGAGGAACCACAGCTTCCT

miR-181b-1 precursor R

TCCGAATTCACTCCATGTTAGAAC

mutant miR-181b-1 F

GGTCACAATCAGGGAAAGGGAAAGTCGG

mutant miR-181b-1 R

CCGACTTTCCCTTTCCCTGATTGTGACC

Bcl-2 3′UTR F

GGT A ACGCGTCATTATCTTGTCACTG

Bcl-2 3′UTR R

GGGCAAGCTTCTATTTAACTCTGACC

Bcl-2 3′UTR mut1 F

ATTAACTTTGCCCGTGACTCTGTTC

Bcl-2 3′UTR mut1 R

GAACAGAGTCACGGGCAAAGTTAAT

Bcl-2 3′UTR mut2 F

GTTAGACCGTTGCCCATGATATAAAAG

Bcl-2 3′UTR mut2 R

CTTTTATATCATGGGCAACGGTCTAAC

  1. F: forward primer; R: reverse primer.